RedHill Biopharma Awarded $1.8 Million in Legal Costs and Expenses by New York Supreme Court in Addition to its Prior $8.25 Million Summary Judgment Win

Kukbo appealed the summary judgment decision on December 4, 2024, and the parties have since completed briefing on that appeal with oral argument tentatively scheduled for the September term. Kukbo also has a right to seek an appeal of the award of legal costs and expenses. About RedHill Biopharma RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on U.S. development and commercialization of drugs for gastrointestinal diseases, infectious diseases and oncology. ...